Alzheimer's Disease
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
HLA-linked complement markers in Alzheimer's and Parkinson's disease: C4 variant (C4B2) a possible marker for senile dementia of the Alzheimer type.
|
6538270 |
1984 |
Diabetes Mellitus, Insulin-Dependent
|
0.030 |
Biomarker
|
disease |
BEFREE |
It is probable that while interaction between certain HLA-DR3 and DR4-containing supratypes is important in conferring susceptibility to Type 1 diabetes, other manifestations of autoimmunity are associated with supratypes containing C4AQ0, and in particular the diabetogenic supratype HLA-B8-C4AQ0-C4B1-BfS-DR3.
|
6332753 |
1984 |
Autoimmune Diseases
|
0.020 |
Biomarker
|
group |
BEFREE |
It is probable that while interaction between certain HLA-DR3 and DR4-containing supratypes is important in conferring susceptibility to Type 1 diabetes, other manifestations of autoimmunity are associated with supratypes containing C4AQ0, and in particular the diabetogenic supratype HLA-B8-C4AQ0-C4B1-BfS-DR3.
|
6332753 |
1984 |
Parkinson Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
HLA-linked complement markers in Alzheimer's and Parkinson's disease: C4 variant (C4B2) a possible marker for senile dementia of the Alzheimer type.
|
6538270 |
1984 |
Diabetes Mellitus, Insulin-Dependent
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
The absolute risk of IDDM was approximately 0.5 in subjects who were homozygous for B18 C4A3 C4BQ0 BfF1 DR3.
|
3865895 |
1985 |
Disease of capillaries
|
0.020 |
GeneticVariation
|
group |
BEFREE |
The association of the rare C4B3 variant with microangiopathy suggests a genetic component of its aetiology.
|
3926068 |
1985 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.010 |
Biomarker
|
disease |
BEFREE |
No significant variation in HLA, BF, C2 or GLO frequencies was found in non-insulin-dependent diabetes mellitus (NIDDM) patients, but there was a significant decrease in C4B 1 and an increase in C4B 2.
|
3879724 |
1985 |
Cyclic neutropenia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Other C4B3 allotypes in informative families have different Ch phenotypes, and the relationships of these within extended major histocompatibility complex haplotypes are discussed in this paper.
|
3865894 |
1985 |
Disease of capillaries
|
0.020 |
Biomarker
|
group |
BEFREE |
The B3 allotype of the fourth component of complement (C4B3) is associated with microangiopathy.
|
3081112 |
1986 |
Congenital adrenal hyperplasia due to 21 hydroxylase deficiency
|
0.020 |
Biomarker
|
disease |
BEFREE |
Two of four siblings expressed the salt-losing form of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH) and had identical human lymphocyte antigen (HLA) and complement C4 (fourth component of complement) types (HLA-A3,C4,B35,C4A3,C4BQO,DR1/A2,C-,B18,C4A3, C4BQO,DR6).
|
3007562 |
1986 |
Congenital adrenal hyperplasia due to 21 hydroxylase deficiency
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Previous studies have shown that the late-onset and cryptic forms of 21-hydroxylase deficiency are highly associated with the HLA supratype HLA-B14,C4A2,C4B1/2,DR1.
|
3013005 |
1986 |
Deficiency of steroid 21-monooxygenase
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Previous studies have shown that the late-onset and cryptic forms of 21-hydroxylase deficiency are highly associated with the HLA supratype HLA-B14,C4A2,C4B1/2,DR1.
|
3013005 |
1986 |
21-hydroxylase deficiency
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Previous studies have shown that the late-onset and cryptic forms of 21-hydroxylase deficiency are highly associated with the HLA supratype HLA-B14,C4A2,C4B1/2,DR1.
|
3013005 |
1986 |
Alzheimer's Disease
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
We were unable to confirm any association between AD and the C4B2 allele.
|
3502596 |
1987 |
Alzheimer's Disease
|
0.070 |
Biomarker
|
disease |
BEFREE |
Sporadic DAT appears to be associated with the complement allotype C4B2 in the major histocompatibility complex, which is linked very closely to HLA.
|
3331113 |
1987 |
Primary biliary cirrhosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
A major histocompatibility complex class III allotype (C4B 2) associated with primary biliary cirrhosis (PBC).
|
3496684 |
1987 |
Alzheimer's Disease
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
In contrast to reported findings we failed to find a significant association between C4B2 gene frequency and Alzheimer's dementia.
|
3350531 |
1988 |
Anterior uveitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
There was an increased incidence of the C4B2 allotype in patients with anterior uveitis (pc less than 0.002), especially in HLA B27 positive males.
|
3259571 |
1988 |
Acute anterior uveitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
There was an increased incidence of the C4B2 allotype in patients with anterior uveitis (pc less than 0.002), especially in HLA B27 positive males.
|
3259571 |
1988 |
Rheumatoid Arthritis
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
The metabolism of the C4 allotypes C4A3,B1 and C4A3,BO was studied in five healthy control subjects and six patients with active immunological disease (five with systemic lupus erythematosus and one with rheumatoid arthritis).
|
2530015 |
1989 |
Rheumatoid Arthritis
|
0.060 |
Biomarker
|
disease |
BEFREE |
We describe here an Nco I restriction fragment length polymorphism of tumor necrosis factor carried by the 8.1 (HLA-A1,B8,BfS,C4AQ0,C4B1,DR3) and the 44.1 (HLA-B44,BfS,C4A3,C4BQ0,DR4) ancestral haplotypes associated with complications of rheumatoid arthritis.
|
2573586 |
1989 |
Rheumatoid Arthritis
|
0.060 |
Biomarker
|
disease |
BEFREE |
These data support the existence of 2 different putative susceptibility haplotypes (HLA-Bw54 or Bw59;C2C; BFS;C4A3;C4B5;DR4.1;DQw4 and C2C;BFS; C4AQ0;C4B1 or C4B2) in Japanese patients with RA.
|
2567598 |
1989 |
Rheumatoid Arthritis
|
0.060 |
Biomarker
|
disease |
BEFREE |
There was no statistically significant differences in C4A or C4B gene frequencies between RA and control groups, although there were trends for C4B*Q0 to be reduced and C4B2 to be increased in DR4 positive RA compared with DR4 positive controls.
|
2711369 |
1989 |
Psoriasis
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Additional findings in the present study were a significant reduction in the C4B*2 allele frequency, a non-significant increase in the Bf*F allele frequency and no difference for Bf or C3 phenotype frequencies in the patients with psoriasis as compared to the controls.
|
2613261 |
1989 |
Immune System Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
The metabolism of the C4 allotypes C4A3,B1 and C4A3,BO was studied in five healthy control subjects and six patients with active immunological disease (five with systemic lupus erythematosus and one with rheumatoid arthritis).
|
2530015 |
1989 |